[ Price : $8.95]
FDA approves an Arrowhead Pharmaceuticals NDA for Redemplo (plozasiran) for reducing dangerously high triglyceride levels in adult...[ Price : $8.95]
Roche says its investigational selective estrogen receptor degrader giredestrant significantly improved invasive disease-free surv...[ Price : $8.95]
FDA warns Opa-Locka, FL-based World Perfumes about CGMP violations in its production of finished drugs as a contract manufacturer.[ Price : $8.95]
CBS News says the federal patent office is taking steps to slow challenges to innovator biologic drug patents by biosimilar drug m...[ Price : $8.95]
A congressional commission on U.S.-China relations calls on Congress to authorize FDA to collect data from drug companies on where...[ Price : $8.95]
FDA denies a citizen petition requesting that it warn patients about whether surgical mesh implanted off-label during cosmetic mas...[ Price : $8.95]
FDA warns North Bergen, NJ-based DermaRite Industries about CGMP, unapproved new drug, and misbranded drug violations in its produ...[ Price : $8.95]
FDA posts a Form 483 that cites significant lapses in aseptic manufacturing practices at Sanofis sterile drug-product facility in ...